Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCelis, Julio E
dc.contributor.authorRingborg, Ulrik
dc.contributor.authorheitor, manuel
dc.contributor.authorBerns, Anton
dc.contributor.authorAlbreht, Tit
dc.contributor.authorGARRALDA, Elena
dc.contributor.authorBaumann, Michael
dc.date.accessioned2023-08-02T07:41:49Z
dc.date.available2023-08-02T07:41:49Z
dc.date.issued2023-06
dc.identifier.citationBaumann M, Celis J, Ringborg U, Heitor M, Berns A, Albreht T, et al. Engaging European society at the forefront of cancer research and care. Mol Oncol. 2023 Jun;17(6):925–45.
dc.identifier.issn1574-7891
dc.identifier.urihttps://hdl.handle.net/11351/10032
dc.descriptionCancer prevention; Cancer research; Policy
dc.description.abstractEuropean cancer research stakeholders met in October 2022 in Heidelberg, Germany, at the 5th Gago conference on European Cancer Policy, to discuss the current cancer research and cancer care policy landscape in Europe. Meeting participants highlighted gaps in the existing European programmes focusing on cancer research, including Europe's Beating Cancer Plan (EBCP), the Mission on Cancer (MoC), Understanding Cancer (UNCAN.eu), and the joint action CRANE, and put forward the next priorities, in the form of the Heidelberg Manifesto for cancer research. This meeting report presents all discussions that shed light on how infrastructures can be effectively shaped for translational, prevention, clinical and outcomes cancer research, with a focus on implementation and sustainability and while engaging patients and the public. In addition, we summarize recommendations on how to introduce frameworks for the digitalization of European cancer research. Finally, we discuss what structures, commitment, and resources are needed to establish a collaborative cancer research environment in Europe to achieve the scale required for innovation.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesMolecular Oncology;17(6)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCàncer - Tractament
dc.subjectEuropa
dc.subjectPolítica
dc.subject.meshNeoplasms
dc.subject.mesh/therapy
dc.subject.meshPolicy
dc.subject.meshEurope
dc.titleEngaging European society at the forefront of cancer research and care
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/1878-0261.13423
dc.subject.decsneoplasias
dc.subject.decs/terapia
dc.subject.decspolíticas
dc.subject.decsEuropa (continente)
dc.relation.publishversionhttps://doi.org/10.1002/1878-0261.13423
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Baumann M] German Cancer Research Center (DKFZ), Heidelberg, Germany. European Academy of Cancer Sciences, Stockholm, Sweden. [Celis J] European Academy of Cancer Sciences, Stockholm, Sweden. Danish Cancer Society Research Center, Copenhagen, Denmark. [Ringborg U] European Academy of Cancer Sciences, Stockholm, Sweden. Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden. [Heitor M] European Academy of Cancer Sciences, Stockholm, Sweden. Center for Innovation, Technology and Policy Research, IN+ @ IS Tecnico, University of Lisbon, Portugal. [Berns A] European Academy of Cancer Sciences, Stockholm, Sweden. The Netherlands Cancer Institute, Amsterdam, The Netherlands. [Albreht T] National Institute of Public Health of Slovenia, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Slovenia. [Garralda E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Cancer Core Europe, Amsterdam, The Netherlands
dc.identifier.pmid36938773
dc.identifier.wos000981931700001
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/H2020/965397
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record